Skip to main content
Clinical Trials/PACTR202202647130754
PACTR202202647130754
Not yet recruiting
Phase 1

Finding solutions to thrive after birth asphyxia in Africa: An open-label dose-finding clinical trial (Phase Ib study) - SANE-Uganda

Research Institute of the McGill University Health Centre0 sites30 target enrollmentFebruary 9, 2022

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Not specified
Sponsor
Research Institute of the McGill University Health Centre
Enrollment
30
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
February 9, 2022
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Research Institute of the McGill University Health Centre

Eligibility Criteria

Inclusion Criteria

  • Male and female neonates meeting the criteria for birth asphyxia:
  • \- Gestational age \= 36 weeks and birth weight \= 1800 g;
  • \- Admitted to Kawempe Hospital or Nsambya Hospital within 48 hours of life;
  • \- Need for continued resuscitation after birth and/or 5\-minute Apgar score \=5;
  • \- Evidence of neonatal encephalopathy by an abnormal neurological exam (modified Sarnat score of 2\-3 or abnormal aEEG).

Exclusion Criteria

  • \- Absent heart rate at 10 minutes/imminent death
  • \- Neonates with major congenital malformations
  • \- Neonates with grade 3 AKI (serum creatinine rise \=3x lowest previous creatinine or creatinine \> 2\.5 mg/dL \= 221 mcmol/L or receipt of dialysis)
  • \- Neonates with intraventricular and/or intraparenchymal hemorrhage on cranial ultrasound (cUS) performed on day 1\-2 of life
  • \- Mother living permanently outside 20km radius of Kawempe Hospital or Nsambya Hospital
  • \- Neonates whose parents are unwilling or unable to give informed written consent to enter the study

Outcomes

Primary Outcomes

Not specified

Similar Trials